{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:05:52Z","timestamp":1771067152347,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,30]]},"DOI":"10.7759\/cureus.9483","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T18:43:49Z","timestamp":1596134629000},"source":"Crossref","is-referenced-by-count":3,"title":["Mucosal Melanoma: A Rare Entity and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Raman J","family":"Sohal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1373::AID-CNCR3>3.0.CO;2-G","article-title":"Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients","volume":"80","author":"Manolidis S","year":"1997","unstructured":"Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997, 80:1373-1386. 10.1002\/(SICI)1097-0142(19971015)80:8&lt;1373::AID-CNCR3&gt;3.0.CO;2-G","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.11.013","article-title":"A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan","volume":"59","author":"Wada H","year":"2004","unstructured":"Wada H, Nemoto K, Ogawa Y, et al.. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys. 2004, 59:495-500. 10.1016\/j.ijrobp.2003.11.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000217236.06585.a9","article-title":"Primary mucosal melanoma of head and neck: prognostic value of clear margins","volume":"116","author":"Penel N","year":"2006","unstructured":"Penel N, Mallet Y, Mirabel X, et al.. Primary mucosal melanoma of head and neck: prognostic value of clear margins. Laryngoscope. 2006, 116:993-995. 10.1097\/01.mlg.0000217236.06585.a9","journal-title":"Laryngoscope"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S182580","article-title":"Contemporary multidisciplinary management of sinonasal mucosal melanoma","volume":"13","author":"Naara S","year":"2020","unstructured":"Naara S, Mukherjee A, Billan S, Gill Z. Contemporary multidisciplinary management of sinonasal mucosal melanoma. OncoTargets Ther. 2020, 13:2289-2298. 10.2147\/OTT.S182580","journal-title":"OncoTargets Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2019.1870","article-title":"An updated review of mucosal melanoma: survival meta\u2011analysis","volume":"11","author":"Hahn HM","year":"2019","unstructured":"Hahn HM, Lee KG, Choi W, et al.. An updated review of mucosal melanoma: survival meta\u2011analysis. Mol Clin Oncol. 2019, 11:116-126. 10.3892\/mco.2019.1870","journal-title":"Mol Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2217\/mmt-2018-0003","article-title":"Combatting mucosal melanoma: recent advances and future perspectives","volume":"5","author":"Tyrrell H","year":"2018","unstructured":"Tyrrell H, Payne M. Combatting mucosal melanoma: recent advances and future perspectives. Melonoma Manag. 2018, 5:MMT11. 10.2217\/mmt-2018-0003","journal-title":"Melonoma Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4103","article-title":"Abscopal effect of radiotherapy in the immunotherapy era: systematic review of reported cases","volume":"11","author":"Dagoglu N","year":"2019","unstructured":"Dagoglu N, Karaman S, Caglar HB, et al.. Abscopal effect of radiotherapy in the immunotherapy era: systematic review of reported cases. Cureus. 2019, 11:4103. 10.7759\/cureus.4103","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000236","article-title":"Radiotherapy and immune checkpoint blockade for melanoma: a promising combinatorial strategy in need of further investigation","volume":"23","author":"Escorcia FE","year":"2017","unstructured":"Escorcia FE, Postow MA, Barker CA. Radiotherapy and immune checkpoint blockade for melanoma: a promising combinatorial strategy in need of further investigation. Cancer J. 2017, 23:32-39. 10.1097\/PPO.0000000000000236","journal-title":"Cancer J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin J","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, et al.. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015, 373:23-34. 10.1056\/NEJMoa1504030","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-018-0774-8","article-title":"Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma","volume":"36","author":"Komatsu T","year":"2018","unstructured":"Komatsu T, Konishi K, Aoshima M, et al.. Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma. Jpn J Radiol. 2018, 36:712-718. 10.1007\/s11604-018-0774-8","journal-title":"Jpn J Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.15_suppl.9004","article-title":"Clinical response, progression-free survival (PFS), and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) vs IPI monotherapy in CheckMate 069 study. Presented at American Society of Clinical Oncology Annual Meeting 2015","volume":"33","author":"Hodi FS","year":"2015","unstructured":"Hodi FS, Postow MA, Chesney JA, et al.. Clinical response, progression-free survival (PFS), and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) vs IPI monotherapy in CheckMate 069 study. Presented at American Society of Clinical Oncology Annual Meeting 2015. J Clin Oncol. 2015, 33:9004. 10.1200\/jco.2015.33.15_suppl.9004","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.02.006","article-title":"Complete and durable response after radiation therapy to primary tumor site of a patient with metastatic anorectal mucosal melanoma with oligoprogression on nivolumab","volume":"5","author":"Wallington DG","year":"2020","unstructured":"Wallington DG, Rashid AS, Buchwald ZS, et al.. Complete and durable response after radiation therapy to primary tumor site of a patient with metastatic anorectal mucosal melanoma with oligoprogression on nivolumab. Adv Radiat Oncol. 2020, 5:503-510. 10.1016\/j.adro.2020.02.006","journal-title":"Adv Radiat Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma","volume":"35","author":"D\u2019Angelo SP","year":"2017","unstructured":"D\u2019Angelo SP, Larkin J, Jeffrey A, et al.. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma. J Clin Oncol. 2017, 35:226-235. 10.1200\/JCO.2016.67.9258","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3936","article-title":"A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma","author":"Postow MA","year":"2020","unstructured":"Postow MA, Knox SJ, Goldman DA, et al.. A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma. Clin Cancer Res. 2020, 10.1158\/1078-0432.CCR-19-3936","journal-title":"Clin Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/34786-mucosal-melanoma-a-rare-entity-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:50Z","timestamp":1707506630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/34786-mucosal-melanoma-a-rare-entity-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.9483","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}